| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |